ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study

March 6, 1992

The President’s Cancer Panel publishes its annual report

May 6, 2011

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021